← Back to all posts
U.S. approves Moderna’s mRNA vaccine for flu—the first of its kind
💉

U.S. approves Moderna’s mRNA vaccine for flu—the first of its kind

This is a groundbreaking moment as the U.S. has approved its first mRNA flu vaccine, called mFlusiva, developed by Moderna. It's shown to be 27 percent more effective than the traditional flu shot, which is fantastic news for those most vulnerable, like adults over 50. The beauty of mRNA technology is that it can be quickly adapted to tackle new virus strains, making it a game-changer for flu seasons ahead. This approval not only enhances our vaccination options but also emphasizes the importance of protecting public health.
Read the original article ↗
Share